πŸ‡ΊπŸ‡Έ FDA
Patent

US 6617350

Inhibitors of aspartyl protease

expired A61PA61P31/18

Quick answer

US patent 6617350 (Inhibitors of aspartyl protease) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Sep 09 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P31/18